Gastroenteropancreatic neuroendocrine tumours are a heterogeneous group of tumours
arising from diffuse endocrine cells, causing unique clinical syndromes. These tumours …

Nuclear medicine is defined as the use of radionuclides for diagnostic and therapeutic
applications. The imaging modalities positron emission tomography (PET) and single …

Only advances that occurred from 2011 to 2014 that either strengthen the previous 2011
guidelines [1, 2] or lead to changes or additional guidelines are reviewed here. Advances …

Gastrinomas are neuroendocrine neoplasms, usually located in the duodenum or pancreas,
that secrete gastrin and cause a clinical syndrome known as Zollinger-Ellison syndrome …

The aim of these guidelines is to assist nuclear medicine physicians in recommending,
performing, reporting and interpreting the results of somatostatin (SST) receptor PET/CT …

This study aimed to evaluate the long-term prognostic usefulness of 18F-FDG PET for
patients with metastatic gastroenteropancreatic neuroendocrine tumors (GEPNETs) …

Somatostatin receptor PET tracers such as [68Ga-DOTA, 1-Nal3]-octreotide (68Ga-
DOTANOC) and [68Ga-DOTA, Tyr3]-octreotate (68Ga-DOTATATE) have shown promising …

Neuroendocrine neoplasms arise in almost every organ of the body and are variably defined
according to the site of origin. This Review focuses on neuroendocrine neoplasms of the …

Neuroendocrine tumors are a heterogeneous group of neoplasms that are best worked up
and managed using a variety of clinical and imaging studies. They are often diagnosed after …

The concept of using a targeting molecule labeled with a diagnostic radionuclide for using
positron emission tomography or single photon emission computed tomography imaging …